Literature DB >> 879735

Effect of probenecid on the blood levels and urinary excretion of cefamandole.

R S Griffith, H R Black, G L Brier, J D Wolny.   

Abstract

Two oral 0.5-g doses of probenecid given 7 and 1 h before a single 1-g intramuscular dose of cefamandole resulted in higher serum levels of cefamandole than when cefamandole was given alone: 37 versus 20 mug per ml of serum, respectively. Cefamandole was not measurable (<0.3 mug/ml) at 8 h when it was given alone, whereas an average 8-h value of 2.9 mug/ml was obtained after pretreatment with probenecid. By prolonging the duration of these high cefamandole levels, probenecid should permit the treatment of more serious clinical infections, including those due to relatively resistant organisms, or permit a reduction in either the dosage of cefamandole or the frequency of administration.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 879735      PMCID: PMC352079          DOI: 10.1128/AAC.11.5.809

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  4 in total

1.  On the mechanism of action of probenecid on renal tubular secretion.

Authors:  I M WEINER; J A WASHINGTON; G H MUDGE
Journal:  Bull Johns Hopkins Hosp       Date:  1960-06

2.  Clinical pharmacology of cefamandole as compared with cephalothin.

Authors:  I W Fong; E D Ralph; E R Engelking; W M Kirby
Journal:  Antimicrob Agents Chemother       Date:  1976-01       Impact factor: 5.191

3.  Pharmacokinetics of cefazolin compared with four other cephalosporins.

Authors:  W M Kirby; C Regamey
Journal:  J Infect Dis       Date:  1973-10       Impact factor: 5.226

4.  Cefamandole: in vitro and clinical pharmacokinetics.

Authors:  R S Griffith; H R Black; G L Brier; J D Wolny
Journal:  Antimicrob Agents Chemother       Date:  1976-11       Impact factor: 5.191

  4 in total
  7 in total

Review 1.  Renal Drug Transporters and Drug Interactions.

Authors:  Anton Ivanyuk; Françoise Livio; Jérôme Biollaz; Thierry Buclin
Journal:  Clin Pharmacokinet       Date:  2017-08       Impact factor: 6.447

2.  Effect of probenecid on the pharmacokinetics of moxalactam.

Authors:  K A DeSante; K S Israel; G L Brier; J D Wolny; B L Hatcher
Journal:  Antimicrob Agents Chemother       Date:  1982-01       Impact factor: 5.191

Review 3.  Cephalosporin-probenecid drug interactions.

Authors:  G R Brown
Journal:  Clin Pharmacokinet       Date:  1993-04       Impact factor: 6.447

Review 4.  Clinical pharmacokinetics of probenecid.

Authors:  R F Cunningham; Z H Israili; P G Dayton
Journal:  Clin Pharmacokinet       Date:  1981 Mar-Apr       Impact factor: 6.447

5.  Failure of probenecid to alter the pharmacokinetics of ceforanide.

Authors:  J F Jovanovich; L D Saravolatz; K Burch; D J Pohlod
Journal:  Antimicrob Agents Chemother       Date:  1981-10       Impact factor: 5.191

6.  Probenecid: an unexplained effect on cephalosporin pharmacology.

Authors:  P G Welling; S Dean; A Selen; M J Kendall; R Wise
Journal:  Br J Clin Pharmacol       Date:  1979-11       Impact factor: 4.335

7.  Single- and multiple-dose pharmacokinetics of fleroxacin, a trifluorinated quinolone, in humans.

Authors:  E Weidekamm; R Portmann; K Suter; C Partos; D Dell; P W Lücker
Journal:  Antimicrob Agents Chemother       Date:  1987-12       Impact factor: 5.191

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.